https://www.thebodypro.com/category/hiv-treatment-strategies/tag/conference-coverage
HIV Treatment Strategies

Conference Coverage

The Latest

Fit for Purpose: Antiretroviral Treatment Optimization Img

Fit for Purpose: Antiretroviral Treatment Optimization

Launched at CROI 2017, this new edition of an annual i-Base publication reviews and updates current and planned research for treatment optimzation studies.

With Possibilities for Long-Acting HIV Treatment, Modern Science Creates Modern ART Img

With Possibilities for Long-Acting HIV Treatment, Modern Science Creates Modern ART

Technology that eliminates daily pill taking, and with it "pill fatigue," stigma and other barriers to adherence, has already proven its value, and is on the horizon for HIV.

Leah H. Rubin, Ph.D.

Women's HIV Status, Viral Suppression Tied to Differences in Cognitive Performance Over Time

Women with HIV tend to perform worse than HIV-negative women on cognitive performance tests, even after many years on treatment, new research finds -- but trends differed depending on the test and on women's treatment success.

Paul Sax, M.D.

Top HIV Researcher Hails a Resurgent Antiretroviral Pipeline

Paul Sax, M.D., discusses the clinical importance of new drugs in development highlighted at CROI 2017 -- and about what else is on the near horizon when it comes to antiretroviral therapies for HIV.

Josep Llibre

Two-Drug Regimen Shines in HIV Treatment Switch Study

A regimen consisting of only two drugs, the integrase inhibitor dolutegravir (Tivicay) and the NNRTI rilpivirine (Edurant), held up well as a maintenance approach in people with HIV who switched from more complex regimens.

Antibodies Could Offer a More 'Natural' and Safer HIV Treatment or Prevention Option Img

Antibodies Could Offer a More 'Natural' and Safer HIV Treatment or Prevention Option

At CROI 2017, Richard Kroup, M.D., from NIAID provided an overview of the recent advances in antibody treatments for HIV prevention and treatment.

CROI 2017 Preview: New Research on HIV Cure and Treatment Img

CROI 2017 Preview: New Research on HIV Cure and Treatment

Here's a preview of some of the noteworthy HIV cure and treatment research being presented at CROI 2017 in Seattle.

Triumeq Virologically Superior to Boosted-Atazanavir Regimen in Women's Trial Img

Triumeq Virologically Superior to Boosted-Atazanavir Regimen in Women's Trial

A fixed-dose combination of dolutegravir plus abacavir/lamivudine proved virologically superior to once-daily ritonavir-boosted atazanavir plus tenofovir/emtricitabine, in a large study of women with HIV.

Joseph Eron Jr., M.D.

If at First an HIV Viral Load Blips, Test, Test (the Same Sample) Again

If an HIV-positive patient's viral load test results come back between 50 copies/mL and 200 copies/mL, consider retesting the same blood sample, Joseph Eron Jr., M.D., recommends. New study results suggest that the retest results may alter a clinicia...

Promo Image

What's Hot in HIV Cure Research?

When it comes to an HIV cure, what do we know now and what are the main areas of focus for future research? Irini Sereti, M.D., reviewed and analyzed the current strategies in cure research, during a presentation at IDWeek 2016 in New Orleans.